Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Levophta

Levophta :
Type Medicine Authorised
Originator B
Agent Spephal
Distributor Spephal
Laboratory Bausch & Lomb
Responsible Party Chauvin
Origin France
Manufacturer Chauvin
Origin France
ATC S01GX02

Your comment will appear shortly after approval

Levophta :

Revision Date : 24/12/2015


Effect Frequency
Administration site reaction Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Application site stinging Common
Blepharitis Very rare
Burning sensation in eye Common
Conjunctivitis Very rare
Corneal calcification Very rare
Dermatitis contact Very rare
Eye irritation Common
Eye oedema Very rare
Eye pain Common
Eye pruritus Very rare
Eye redness Very rare
Eyelid oedema Uncommon
Headache Very rare
Hypersensitivity Very rare
Lacrimation Very rare
Ocular hyperaemia Very rare
Urticaria Very rare
Vision blurred Common

Different Units By MoH Code

Levophta  MoH 2520 :
Form Eye drops
Packaging Bottle (PE)
Package Size 5ml
Strength 0.5mg/ml
Public Price 694113,42 L.L.
Stratum A1
NSSF ✔
Quarantine ✘
Reg. Number 208343/97
Submission date 01/01/1997
Registration Year 1997


Price Comparison

● Country: Lebanon
● Form: Eye drops
● Package Size: 5ml
● Public Price: 694113.42 LBP ( 694,113.42 LBP )
● Pack size unit used: 100
● Cost/Unit: 6941,13 LBP ( 6,941.00 LBP )
● Pricing Date: 05/09/2023

● Country: France
● Package Size: 5ml
● Public Price: 6.98 EUR ( 128,292.75 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,0698 EUR ( 0.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Allergic conjunctivitis :
● Cost/Unit: 6941,13 LBP ( 6,941.00 LBP )
● Cost/Day: LBP ( 0.00 LBP )
● Cost/Month: LBP ( 0.00 LBP )
Allergic conjunctivitis :
● Cost/Unit: 0,0698 EUR ( 0.00 LBP )
● Cost/Day: EUR ( 0.00 LBP )
● Cost/Month: EUR ( 0.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info